Blackstone Funds Sell Stake in ZO Skin Health to Galderma
1 report, 1 independent
Updated Oct 22
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Blackstone funds are involved as sellers in Galderma’s agreement to acquire ZO Skin Health for an enterprise value of $1.5 billion. The transaction is subject to regulatory approvals and is expected to close in the fourth quarter of 2026 or early 2027. Separately, Blackstone Inc. reported total distributable earnings of $1.72 billion, which was down 9% from the previous year.
From finchannel.com
Why it matters
The acquisition represents a significant corporate transaction where Blackstone funds are selling their stake in ZO Skin Health to Galderma. This activity reflects the ongoing M&A movement within the alternative asset management sector.
From finchannel.com
Who's involved
- GaldermaThe company acquiring ZO Skin Health
- Blackstone Inc.The investment firm whose funds are selling their stake in ZO Skin Health
Keep exploring
The entities involved
-
Galderma
company
Nothing else this week.
-
Blackstone Inc.
American alternative investment company